Effect of indomethacin,diclofenac or naproxen on prevention of pancreatitis

Comparison of the effect of rectal Indomethacin, Diclofenac or Naproxen on prevention of post Endoscopic cholangiopancreatography pancreatitis

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

IRCT

Registry ID

IRCT2014100111192N3

Enrollment

180

Registered

2014-11-08

Start date

2015-01-01

Completion date

Unknown

Last updated

2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

pancreatitis. Other acute pancreatitis

Interventions

Group1: Adminstration of single dose of 100 mg rectal indomethacine just before doing Endoscopic cholangiopancreatography Group2: Administration of single dose of 100 mg rectal diclofenac just befo

Prevention

Group1: Adminstration of single dose of 100 mg rectal indomethacine just before doing Endoscopic cholangiopancreatography Group2: Administration of single dose of 100 mg rectal diclofenac just bef

Eligibility

Sex/Gender

All

Age

18 Years to 70 Years

Inclusion criteria

Inclusion criteria: Patients undergoing ERCP in Taleghani hospital by taking written consent

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Pancreatitis. Timepoint: 10 days after doing ERCP. Method of measurement: clinical evaluation.	—

Secondary

Measure	Time frame
Gastrointestinal bleeding. Timepoint: 10 days after doing ERCP. Method of measurement: clinical evaluation.;Hypersensitivity reactions. Timepoint: 10 days after doing ERCP. Method of measurement: Clinical observation.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMohammad Abbasinazari

School of pharmacy, Shahid Beheshti University of Medical Sciences

m_abbasi@sbmu.ac.ir+98 21 8887 3704

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026